Advertisement

Ads Placeholder
Loading...

Roche Holding AG

ROP.SW•SIX
Healthcare
Drug Manufacturers - General
CHF318.00
CHF-0.30(-0.09%)
Swiss Market opens in 18h 40m

Roche Holding AG (ROP.SW) Stock Overview

Explore Roche Holding AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap253.1B
P/E Ratio19.65
EPS (TTM)$16.05
ROE0.41%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ROP.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Roche Holding AG (ROP.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.65 and a market capitalization of 253.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.09%
5-Day Change
2.22%
1-Month Change
-10.52%
3-Month Change
-2.30%
6-Month Change
10.88%
Year-to-Date (YTD) Change
-2.30%
1-Year Change
14.18%
3-Year Change
22.17%
5-Year Change
4.16%
All-Time (Max) Change
407.26%

Contact Information

https://www.roche.com
41 61 688 11 11
Grenzacherstrasse 124, Basel, NaN, 4070

Company Facts

1,032,490 Employees
IPO DateAug 20, 2003
CountryCH
Actively Trading

Frequently Asked Questions